You are here

Article metrics

Article menu
XML
Infectious diseases
Research
A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 201837335
Feb 201819164
Mar 201837324
Apr 201835315
May 201830205
Jun 201827150
Jul 20181282
Aug 20181282
Sep 2018995
Oct 201815112
Nov 201819153
Dec 2018972
Jan 20191082
Feb 20191197
Mar 201913137
Apr 2019543
May 20191163
Jun 2019643
Jul 201911114
Aug 2019555
Oct 2019642
Nov 201911115
Dec 2019666
Jan 20201191
Feb 202016128
Mar 2020151512
May 2020883
Jun 202015143
Jul 20201498
Aug 202010107
Sep 202022187
Oct 202024224
Nov 202019178
Dec 202015154
Jan 202111810
Feb 2021863
Mar 202112103
Apr 2021230
May 2021884
Jun 2021442
Jul 202110102
Aug 202113137
Sep 2021775
Oct 2021141416
Nov 2021171714
Dec 2021252410
Jan 202232299
Feb 202218188
Mar 202217174
Apr 202218141
May 202218189
Jun 202224238
Jul 202214132
Aug 202221214
Sep 202213139
Oct 202219168
Nov 202233314
Dec 202218173
Jan 2023242211
Feb 202315146
Mar 202314145
Apr 20231172
May 202317147
Jun 202321174
Jul 2023232110
Aug 20231496
Sep 202318182
Oct 202320185
Nov 202315120
Dec 202326266
Jan 202417174
Feb 202425168
Mar 2024201653
Apr 2024242515
Total12051055440